Wedbush Analyst Reiterates Confidence in Kura Oncology with Outperform Rating and 37 Price Target
Wedbush analyst Robert Driscoll has once again expressed his confidence in Kura Oncology (NASDAQ: KURA), giving it an "Outperform" rating ...
© 2024 Stocks Today